Catalyst Wire Dossier Catalyst Wire Dossier

IMG-007

· Inmagene LLC
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for IMG-007, covering 2024-12-12 to 2026-02-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]

See pricing